$WAT

Waters Corporation · NYSE · Healthcare

409.38-4.18 (-1.01%)
Market cap
40.20B
Volume
352.1K
P/E
104.17
Day range
402.83 – 412.10
52w range
282.77 – 426.22
Analyst target
440.65

AI Summary

Generating a unique summary for WAT

AI-generated for information only — not investment advice.

Share this ticker

$WAT -1.01% at 409.38
Terry Smith and 0 other tracked billionaires hold it.
$JNJ $NTRA $LLY
https://billionairestrading.com/stocks/WAT
Post to StocktwitsShare on XRedditLinkedIn

Company summary

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Industry: Diagnostics & ResearchEmployees: 16,000HQ: United StatesWebsite

Institutional ownership

Institutions hold 102.38% · insiders 0.10% · 1,623 institutions

HolderSharesValue% heldReported
Blackrock Inc.8.48M$3.47B8.64%2026-06-30
Vanguard Capital Management LLC6.42M$2.63B6.53%2026-06-30
Vanguard Portfolio Management LLC4.74M$1.94B4.83%2026-06-30
Massachusetts Financial Services Co.4.63M$1.89B4.71%2026-06-30
State Street Corporation4.38M$1.79B4.46%2026-06-30
T. Rowe Price Investment Management, Inc.3.82M$1.56B3.89%2026-06-30
Invesco Ltd.3.49M$1.43B3.56%2026-06-30
Alliancebernstein L.P.2.69M$1.10B2.74%2026-06-30
Geode Capital Management, LLC2.64M$1.08B2.68%2026-06-30
Fundsmith LLP2.27M$930.78M2.31%2026-06-30

Hedge fund & billionaire activity

Insider transactions

InsiderRoleTransactionSharesDate
KUEBLER CHRISTOPHER ADirectorConversion of Exercise of derivative security at price 136.43 per share.3.6K2026-08-06
KUEBLER CHRISTOPHER ADirectorSale at price 397.94 per share.3.6K2026-08-06
JIANG WEIDirectorStock Award(Grant) at price 0.00 per share.67.002026-06-30
KNIGHT HEATHERDirectorStock Award(Grant) at price 0.00 per share.63.002026-06-30
JIANG WEIDirectorStock Award(Grant) at price 0.00 per share.64.002026-03-31
KNIGHT HEATHERDirectorStock Award(Grant) at price 0.00 per share.68.002026-03-31
JIANG WEIDirectorPurchase at price 289.46 per share.500.002026-03-16
FEARON RICHARD HDirectorPurchase at price 306.34 per share.1.0K2026-03-06
ORNSKOV FLEMMINGDirectorStock Award(Grant) at price 0.00 per share.336.002026-02-25
CHAUBAL AMOLChief Financial OfficerStock Award(Grant) at price 0.00 per share.1.5K2026-02-25
BATRA UDITChief Executive OfficerStock Award(Grant) at price 0.00 per share.5.2K2026-02-25
FRASER CLAIREDirectorStock Award(Grant) at price 0.00 per share.358.002026-02-25

Analyst ratings

Consensus score 1.71 (1 = strong buy, 5 = sell) · mean target 440.65

  • Piper SandlerOverweightup2026-08-27
  • CitigroupBuymain2026-08-10
  • TD CowenBuyup2026-08-05
  • RBC CapitalOutperformmain2026-08-05
  • Evercore ISI GroupOutperformmain2026-08-05
  • Wells FargoEqual-Weightmain2026-08-05
  • BarclaysOverweightmain2026-08-05
  • Goldman SachsBuymain2026-07-14
  • Morgan StanleyEqual-Weightmain2026-07-09
  • RBC CapitalOutperforminit2026-07-09

Earnings

Next report: 2026-10-30

QuarterEPS actualEPS estimateSurprise
3Q20253.403.220.18
4Q20254.534.510.02
1Q20262.702.310.39
2Q20263.053.010.04

SEC filings

  • 8-KCorporate Changes & Voting Matters2026-08-21Open
  • 10-QPeriodic Financial Reports2026-08-11Open
  • 8-KCorporate Changes & Voting Matters2026-08-04Open
  • 11-KAnnual report of employee stock purchase2026-06-25Open
  • SDSpecialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)2026-05-29Open
  • 8-KCorporate Changes & Voting Matters2026-05-22Open
  • 10-QPeriodic Financial Reports2026-05-12Open
  • 8-KCorporate Changes & Voting Matters2026-05-05Open
  • DEFA14AProxy Statements2026-04-09Open
  • 8-KCorporate Changes & Voting Matters2026-03-23Open

Latest WAT news

  • Waters (WAT) Stock Could Be A Bargain On Cash Flow Yet Fully Priced On Sales

    Waters stock has put in a strong multi year gain, yet the valuation signals are split, with an intrinsic value estimate based on a Discounted Cash Flow (DCF) model pointing to upside while the earnings multiple checks lean expensive. Over the past 3 years, Waters has returned about 53%, which puts more pressure on today’s entry price to be well supported by fundamentals. The company’s ability to keep converting its specialized analytical instruments and services into steady cash flow can...

    Fri, 04 Sep 2026 11:11:55 +0000

  • Waters (WAT) Raised Guidance, Is The Stock Still Cheap?

    Waters (WAT) stock is back in focus after the company reported Q2 2026 adjusted earnings of $3.05 per share and raised its full year guidance for organic revenue growth and adjusted earnings. At a share price of $413.56, Waters has posted a 30 day share price return of 4.41% and a 90 day share price return of 13.19%. The 1 year total shareholder return of 38% and 3 year total shareholder return of 53% point to building momentum supported by upgraded guidance and recent leadership...

    Fri, 04 Sep 2026 03:09:03 +0000

  • Why Is Waters (WAT) Up 3.1% Since Last Earnings Report?

    Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

    Thu, 03 Sep 2026 15:30:27 +0000

  • Is Wall Street Bullish or Bearish on Waters Corporation Stock?

    Although Waters Corporation has exceeded the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

    Fri, 28 Aug 2026 07:02:54 +0000

  • Research Tools & Consumables Stocks Q2 Highlights: Waters Corporation (NYSE:WAT)

    The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Waters Corporation (NYSE:WAT) and the rest of the research tools & consumables stocks fared in Q2.

    Wed, 26 Aug 2026 18:03:13 +0000

  • Waters Corporation to Present at the Wells Fargo Healthcare Conference

    Waters Corporation (NYSE: WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9th, 2026, at 10:15 AM Eastern Time.

    Wed, 26 Aug 2026 13:00:00 +0000

  • Waters (WAT) Q2 2026 Earnings Call Transcript

    Organic growth accelerated to 9% as acquired units and legacy markets recovered.

    Tue, 11 Aug 2026 16:44:58 +0000

  • Waters Q2 Earnings Call Highlights

    Waters (NYSE:WAT) reported second-quarter 2026 revenue of $1.645 billion, driven by 9% organic constant-currency growth and a 4% increase in revenue from its acquired Biosciences and Diagnostic Solutions businesses. The company raised its full-year outlook for organic revenue, acquired-business reve

    Sun, 09 Aug 2026 15:04:20 +0000

Related Healthcare stocks